Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for SRTA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -4.203M
March 31, 2026 -0.53M
December 31, 2025 -1.742M
September 30, 2025 -7.244M
June 30, 2025 -1.137M
March 31, 2025 -4.246M
December 31, 2024 -3.874M
September 30, 2024 -1.754M
June 30, 2024 -0.222M
March 31, 2024 0.091M
December 31, 2023 -0.139M
September 30, 2023 0.009M
June 30, 2023 0.00
Date Value
March 31, 2023 0.054M
December 31, 2022 -1.165M
September 30, 2022 0.002M
June 30, 2022 3.039M
December 31, 2021 -2.96M
September 30, 2021 0.181M
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 -0.2584M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Dogecoin Cash, Inc. 0.0001M
Privia Health Group, Inc. 0.826M
Syra Health Corp. -0.0798M
BrightSpring Health Services, Inc. -350.49M
Cryo-Cell International, Inc. -1.623M